Literature DB >> 3557757

Bone levels of cephradine and cefuroxime after intravenous administration in patients undergoing total hip replacement.

T J Cain, G T Jones, P Woods.   

Abstract

A randomised, comparative study is reported of single intravenous doses of cephradine 2 g or cefuroxime 1.5 g given as prophylactic cover for total hip replacements in 40 patients. The serum and bone levels of cephalosporin achieved were higher in the cephradine treated group in proportion to the higher dose employed. Both agents provided adequate bone levels on average, cephradine 25.34 mcg/g, cefuroxime 17.39 mcg/g, although bone penetration was more variable with cefuroxime.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3557757     DOI: 10.1007/BF00266059

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  5 in total

1.  The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement.

Authors:  B A Cunha; H R Gossling; H S Pasternak; C H Nightingale; R Quintiliani
Journal:  J Bone Joint Surg Am       Date:  1977-10       Impact factor: 5.284

2.  Bone concentrations of cefuroxime and cefamandole in the femoral head in 96 patients undergoing total hip replacement surgery.

Authors:  D A Leigh; J Marriner; D Nisbet; H D Powell; J C Church; K Wise
Journal:  J Antimicrob Chemother       Date:  1982-04       Impact factor: 5.790

3.  Prophylactic cefazolin versus placebo in total hip replacement. Report of a multicentre double-blind randomised trial.

Authors:  C Hill; R Flamant; F Mazas; J Evrard
Journal:  Lancet       Date:  1981-04-11       Impact factor: 79.321

4.  Bacteria isolated from deep joint sepsis after operation for total hip or knee replacement and the sources of the infections with Staphylococcus aureus.

Authors:  O M Lidwell; E J Lowbury; W Whyte; R Blowers; S J Stanley; D Lowe
Journal:  J Hosp Infect       Date:  1983-03       Impact factor: 3.926

5.  Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomised study.

Authors:  O M Lidwell; E J Lowbury; W Whyte; R Blowers; S J Stanley; D Lowe
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-03
  5 in total
  2 in total

Review 1.  Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Authors:  Cornelia B Landersdorfer; Jürgen B Bulitta; Martina Kinzig; Ulrike Holzgrabe; Fritz Sörgel
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

2.  Pharmacokinetic Model for Cefuroxime Dosing during Cardiac Surgery under Cardiopulmonary Bypass.

Authors:  J Lanoiselée; P J Zufferey; S Hodin; N Tamisier; L Gergelé; J C Palao; S Campisi; S Molliex; J Morel; X Delavenne; E Ollier
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.